Cipla Limited (NSE:CIPLA)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceutical and Related Products	278.28B	272.67B	248.42B	219.99B	213.51B
Pharmaceutical and Related Products Growth	2.06%	9.76%	12.92%	3.04%	13.10%
New Ventures	-	-	11.12B	10.55B	5.32B
New Ventures Growth	-	-	5.39%	98.46%	32.46%
Inter Segment Revenue	-	-	-1.80B	-3.01B	-1.19B
Total	278.28B	272.67B	257.74B	227.53B	217.63B
Total Growth	2.06%	5.79%	13.28%	4.55%	13.59%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
South Africa	42.85B	38.26B	36.66B	23.35B	26.33B
South Africa Growth	11.99%	4.38%	57.00%	-11.31%	14.33%
United States of America	68.72B	78.99B	75.02B	59.09B	44.31B
United States of America Growth	-13.01%	5.30%	26.96%	33.34%	8.31%
India	126.80B	116.15B	108.73B	98.69B	98.28B
India Growth	9.17%	6.82%	10.18%	0.42%	27.04%
Rest of The World	43.25B	42.07B	37.33B	46.41B	48.72B
Rest of The World Growth	2.80%	12.70%	-19.55%	-4.74%	-3.14%
Total	281.63B	275.48B	257.74B	227.53B	217.63B
Total Growth	2.23%	6.88%	13.28%	4.55%	13.59%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 9, 2026

Data Sources Report a data error